Physician profile
Bodo E Knudsen
NPI 1467401489
$108,093.38
in general payments reported to CMS, 2019-2025
8 companies · $290 in 2025
The $290 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67K · 2020: $8,190 · 2021: $5,748 · 2022: $2,802 · 2023: $24K · 2024: $104 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Travel and Lodging: $3,099 · Food and Beverage: $541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,565.00 |
| Travel and Lodging | $3,099.21 |
| Food and Beverage | $541.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $38,755.37 | 2019-2025 | Lithovue, Lithoclast |
| Gyrus Acmi, INC. | $35,550.86 | 2019-2023 | Soltive |
| Olympus America INC. | $22,640.26 | 2019-2025 | Soltive, Itind System, Soltive |
| C. R. Bard, INC. & Subsidiaries | $10,430.64 | 2019-2021 | |
| Verathon INC. | $600.00 | 2021 | |
| Olympus Corporation of The Americas | $54.94 | 2019 | |
| Calyxo, INC. | $40.58 | 2025 | Cvac Aspiration System |
| Becton, Dickinson and Company | $20.73 | 2025 | Bard X-Force Balloon Dilation Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bodo Knudsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.